Similar Papers

Paper Title
Journal
Date
Author
Rheumatology meeting: Efficacy, safety of biologics central focus
Maria G Tanzi
Pharmacy Today | VOL. 19
Maria G TanziMaria G Tanzi
01 Apr 2013
AB0238 USEFULNESS OF RAPID3 IN ASSESSING UNMET NEEDS OF RHEUMATOID ARTHRITIS PATIENTS FROM THE T-FLAG STUDY
M Suzuki ... S Imagama
Annals of the Rheumatic Diseases | VOL. 82
M Suzuki, et. al.M Suzuki ... S Imagama
30 May 2023
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
Imane Bardan ... Berit Flatø
The Journal of Rheumatology | VOL. 50
Imane Bardan, et. al.Imane Bardan ... Berit Flatø
15 Nov 2022
Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience
H Singh ... S Arya
Clinical Rheumatology | VOL. 31
H Singh, et. al.H Singh ... S Arya
15 Sep 2012
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study
Antonio Manzo ... Serena Bugatti
RMD Open | VOL. 11
Antonio Manzo, et. al.Antonio Manzo ... Serena Bugatti
29 Jan 2025
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison
Gustaf Magnus Bruze ... Martin Neovius
RMD Open | VOL. 11
Gustaf Magnus Bruze, et. al.Gustaf Magnus Bruze ... Martin Neovius
29 Jan 2025
Trends in work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs): Data from the German National Database (2010-2022).
Carlo Veltri ... Johanna Callhoff
RMD open | VOL. 11
Carlo Veltri, et. al.Carlo Veltri ... Johanna Callhoff
25 Jan 2025
Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease
Liseth De Wolff ... Hendrika Bootsma
RMD Open | VOL. 11
Liseth De Wolff, et. al.Liseth De Wolff ... Hendrika Bootsma
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.